Across TCGA pan-cancer cohorts, ANKRD20A3P RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of ANKRD20A3P’s most consistent transcriptional readouts.
The strongest signal is observed in lung adenocarcinoma (LUAD), where ANKRD20A3P RNA is repressed in tumor relative to normal tissue. In most cancer types ANKRD20A3P is over-expressed in tumor, although a few such as LUAD show the opposite, repressed pattern.
LUAD are the cancer types where ANKRD20A3P tumor–normal differential expression is most reproducible.